EMBECTA CORP. Share Repurchase Authorization
EMBECTA CORP. (EMBC) had Share Repurchase Authorization of $100.00 million as of 2026-05-31, per its 10-Q filed 2026-08-07.
Financial Statements › Notes
srt:StockRepurchaseProgramAuthorizedAmount1 · last filed 2026-08-07
- 2026-05-31: Stock Repurchase Program Authorized Amount1 $100.00M.
| Period end | Stock Repurchase Program Authorized Amount1 |
|---|---|
| 2026-05-31 | $100.00M 10-Q · filed 2026-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |